ELDN

ELEDON PHARMACEUTICALS INC

ELDN·28617K101·US·Common Stock·Healthcare - Biotechnology-13D/G

ELDN (ELEDON PHARMACEUTICALS INC) is held by 84 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($20.2M), VANGUARD CAPITAL MANAGEMENT LLC ($13.5M), GOLDMAN SACHS GROUP INC ($9.9M). Net institutional sentiment: Bullish.

84
Holders
(7 Elite)
$103.3M
Total Value
88% (82)
Consensus
72 buying - 10 selling
13F: Insider & Congress: Updated regularly
ELDN

Smart Money Verdict

View all
Loading verdict
Held by 84 funds
7 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders none · Activists Jul 31, 2026 · Congress none

ActivistVAVanguard Capital Management5.0%Jul 31, 2026
ActivistBLBVF PARTNERS L P/IL10.0%May 15, 2026
ActivistBlackRock, Inc.BlackRock, Inc.5.8%Apr 27, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
5.1M(+16.9%)$20.2M0.0%+12.47%
33
Increased
3.4M(+3.8%)$13.5M0.0%+31.25%
29
Increased
2.5M(+578.3%)$9.9M0.0%-9.16%
45
Decreased
2.1M(-14.8%)$8.3M0.0%+27.69%
0
Increased
2M(+9.2%)$7.7M0.0%+0.72%
30
Increased
1.6M(+40.5%)$6.4M0.0%+14.73%
36
Increased
1M(+91.5%)$4.1M0.0%+20.07%
42
New
979,712$3.9M0.0%-14.97%
37
Increased
883,097(+1.6%)$3.5M0.0%+32.76%
27
Increased
616,399(+13.3%)$2.4M0.0%+8.53%
30
Increased
581,028(+237.0%)$2.3M0.0%-1.76%
42
Increased
538,738(+703.1%)$2.1M0.0%-12.74%
42
Increased
533,365(+24.1%)$2.1M0.0%+20.53%
32
Increased
528,963(+5.0%)$2.1M0.0%+30.42%
27
Increased
485,092(+234.2%)$1.9M0.0%-9.22%
42
Increased
304,707(+33.3%)$1.2M0.0%+50.64%
32
Increased
252,232(+129.4%)$993,7940.0%-1.86%
40
Increased
247,404(+27.5%)$974,7720.0%+12.97%
31
New
215,973$850,9340.0%-14.97%
34
Increased
209,097(+174.1%)$823,8420.0%-3.84%
40

Showing 1-20 of 85

1 / 5
ELDNELDNELEDON PHARMACEUTICALS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used